Home » Topics » Regulatory

Regulatory
RSS

Budesonide cleared in Canada for Crohn's disease

April 4, 1997

Digital Gene Technologies and Recordati collaborate on atherosclerosis research

April 4, 1997

New indication for liquid Nutropin approved by FDA

April 4, 1997

New epilepsy option approved in the U.S.

April 2, 1997

FDA tentatively approves generic acyclovir

April 2, 1997

Cytogen's Quadramet approved by FDA

April 1, 1997

Syrup formulation of Zofran available in the U.K.

April 1, 1997

U.K. introduction for intranasal sumatriptan

April 1, 1997

Extended treatment with Intron A for hepatitis C cleared by FDA

April 1, 1997

Subcutaneous IL-2 boosts CD4 cell counts in HIV-infected patients

March 26, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 7, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 7, 2024.
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...
Sanofi bets on Resalis’ oligonucleotide RES-010 for obesity
BioWorld
After missing out on the glucagon-like peptide 1 obesity market, Sanofi SA is prospecting for next-generation drugs and is making a strategic equity investment in...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.